Zimmer (ZMH) PT Lifted Sharply at Piper Jaffray Ahead of Biomet Deal
Tweet Send to a Friend
Piper Jaffray analyst Matt Miksic reiterated an Overweight rating and boosted his price target Zimmer Holdings (NYSE: ZMH) to $148.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE